183 related articles for article (PubMed ID: 12823090)
1. A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities.
Fontaine CS; Hynan LS; Koch K; Martin-Cook K; Svetlik D; Weiner MF
J Clin Psychiatry; 2003 Jun; 64(6):726-30. PubMed ID: 12823090
[TBL] [Abstract][Full Text] [Related]
2. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
Martin H; Slyk MP; Deymann S; Cornacchione MJ
J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
[TBL] [Abstract][Full Text] [Related]
3. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Conley RR; Mahmoud R
Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
[TBL] [Abstract][Full Text] [Related]
5. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia.
Ho BC; Miller D; Nopoulos P; Andreasen NC
J Clin Psychiatry; 1999 Oct; 60(10):658-63. PubMed ID: 10549681
[TBL] [Abstract][Full Text] [Related]
6. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL
J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
[TBL] [Abstract][Full Text] [Related]
8. Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.
Ellingrod VL; Schultz SK; Ekstam-Smith K; Kutscher E; Turvey C; Arndt S
Pharmacotherapy; 2002 Jan; 22(1):1-5. PubMed ID: 11794418
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
Tran PV; Hamilton SH; Kuntz AJ; Potvin JH; Andersen SW; Beasley C; Tollefson GD
J Clin Psychopharmacol; 1997 Oct; 17(5):407-18. PubMed ID: 9315992
[TBL] [Abstract][Full Text] [Related]
10. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
Katz IR; Jeste DV; Mintzer JE; Clyde C; Napolitano J; Brecher M
J Clin Psychiatry; 1999 Feb; 60(2):107-15. PubMed ID: 10084637
[TBL] [Abstract][Full Text] [Related]
11. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.
Deberdt WG; Dysken MW; Rappaport SA; Feldman PD; Young CA; Hay DP; Lehman DL; Dossenbach M; Degenhardt EK; Breier A
Am J Geriatr Psychiatry; 2005 Aug; 13(8):722-30. PubMed ID: 16085789
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
13. Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
Mulsant BH; Gharabawi GM; Bossie CA; Mao L; Martinez RA; Tune LE; Greenspan AJ; Bastean JN; Pollock BG
J Clin Psychiatry; 2004 Dec; 65(12):1708-14. PubMed ID: 15641877
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine: an updated review of its use in the management of schizophrenia.
Bhana N; Foster RH; Olney R; Plosker GL
Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
[TBL] [Abstract][Full Text] [Related]
16. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A
J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
[TBL] [Abstract][Full Text] [Related]
17. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Casey DE; Daniel DG; Wassef AA; Tracy KA; Wozniak P; Sommerville KW
Neuropsychopharmacology; 2003 Jan; 28(1):182-92. PubMed ID: 12496955
[TBL] [Abstract][Full Text] [Related]
18. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Guille C; Sachs GS; Ghaemi SN
J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.
Street JS; Clark WS; Gannon KS; Cummings JL; Bymaster FP; Tamura RN; Mitan SJ; Kadam DL; Sanger TM; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2000 Oct; 57(10):968-76. PubMed ID: 11015815
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.
Rainer M; Haushofer M; Pfolz H; Struhal C; Wick W
Eur Psychiatry; 2007 Sep; 22(6):395-403. PubMed ID: 17482432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]